S&P 500 Healthcare Sector SEC Filings — April 17, 2026

USA S&P 500 Healthcare

17 high priority33 medium priority50 total filings analysed

Executive Summary

Across 50 filings in the USA S&P 500 Healthcare stream (with broader financial context from first 28 new filings), healthcare activity remains sparse, focusing on biotech governance (Tyra Biosciences, Dare Bioscience, Emmaus Life Sciences director changes) and funding (Revolution Medicines $500M convertible notes, CEL-SCI S-1 offering), signaling pipeline investment amid neutral sentiment. Abbott Laboratories resolved infant formula litigation overhang via preliminary settlement approval. Dominating filings are regional banks' Q1 2026 earnings (FFIN +16.6% YoY NI, Regions +15% adj EPS YoY, Truist +25% EPS YoY, Ally +90% adj EPS YoY, Chemung +53.3% YoY NI), averaging 37% YoY net income/EPS growth but with QoQ NII declines (-0.8% to -2.8%) and NIM compression (-3 to -5 bps in 3/5) due to deposit shifts. Capital allocation leans shareholder-friendly (Truist $1.1B buyback, News Corp $1B program, Chemung $0.34 dividend), with proxy season ramping (10+ AGMs May-June). No insider trading patterns detected; sentiment mixed (positive in appointments/debt, neutral in proxies/13Fs). Portfolio implication: Opportunistic healthcare catalysts amid resilient bank earnings, watch NIM trends and biotech AGMs for conviction signals.

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from April 10, 2026.

Investment Signals(12)

  • Issued $500M 0.50% convertible senior notes due 2033 (conversion ~$198.80/share, redeemable post-2030 if stock >130% conversion price), low-cost funding for biotech R&D

  • Adjusted EPS $1.11 (+90% YoY from $0.58 loss), core ROTCE 11.1% (+440 bps YoY), CET1 10.1% (+60 bps YoY), retail auto NCO 197 bps (-15 bps YoY)

  • Net income $1.38B (+19% YoY), diluted EPS $1.09 (+25% YoY), ROTCE 13.8% (targets 16-18%), repurchased $1.1B shares, CET1 stable 10.8%

  • Record Q1 NI $9.2M (+53.3% YoY, +19.5% QoQ), NII $23.6M (+19.2% YoY), ann loan growth 7.5%, efficiency ratio record 58.27%

  • Adjusted EPS $0.62 (+15% YoY), total revenue $1.873B (+5% YoY), loans +2.4% QoQ (business lending +4.3%), NPL 0.71% (-2 bps QoQ), ROATCE 18.26%

  • Q1 NI $71.54M (+16.6% YoY), NII $134.79M (+13.5% YoY), NIM 3.86%, NPA 0.66% (-12 bps YoY), trust fees +5.7% YoY

  • Appointed Habib Dable (ex-Acceleron CEO) as Class II director, granted 44,400 options vesting 36 months, board expanded to 10, independence affirmed

  • Secured $5B 364-day revolver (SOFR margins 0.585-1.085% based on ratings), enhances liquidity vs prior facilities

  • Appointed Doug Bland (ex-PayPal Global Credit leader) as CEO effective Apr 20, 2026, with 30+ yrs consumer finance exp

  • Elected Hirotaka Inoue (Nippon Life, ex-Bank of Japan) as director effective Apr 21 replacing Kimura, adds insurance/regulatory expertise

  • News Corp(BULLISH)

    Ongoing $1B stock repurchase program (Class A/B shares), daily ASX disclosures signal commitment to returns

  • Revenues +23.2% YoY to Ps41.4B ($2.3B), net profit +12.7% YoY, aeronautical +19.4%, dividends Ps16.84/share

Risk Flags(10)

Opportunities(10)

Sector Themes(6)

  • Bank Earnings YoY Strength vs QoQ Softness(MIXED)

    5/7 financial reporters (FFIN, Regions, Truist, Ally, Chemung) avg +37% YoY NI/EPS growth, but 4/5 NII -0.8-2.8% QoQ, NIM compress -3-5 bps in 3/5; implies deposit competition, watch Fed cuts

  • Biotech Governance Momentum(BULLISH)

    4/50 filings (Tyra, Dare, Emmaus, CEL-SCI) show director adds/reclassifications/appointments, positive sentiment avg 6/10 materiality, no insider sales; signals board conviction pre-AGMs

  • Low-Cost Debt Access(POSITIVE)

    Revolution Medicines 0.50% conv notes, Danaher $5B revolver (0.585% margins); healthcare/financials tap markets amid high rates, vs equity dilution risks

  • Proxy/AGM Surge(NEUTRAL)

    12/50 filings (Chime DEF14A/DEFA14A, FrontView, Tyra, MFA) schedule May-June votes on directors/auditors/say-on-pay; monitor pass rates for governance signals

  • Capital Allocation Shareholder Focus(POSITIVE)

    Buybacks (Truist $1.1B, News $1B program), dividends (Chemung $0.34, Pacific Ps16.84); 3/50 highlight returns over reinvestment amid mixed ops

  • 13F Stability/No Shifts(NEUTRAL)

    14/50 13Fs (First City, Stonebridge, etc.) total ~$5B+ AUM, heavy ETFs/tech (NVIDIA/Apple top), sole discretion, no PoP changes; passive flows steady

Watch List(8)

Filing Analyses(50)
MFA FINANCIAL, INC.DEFA14Aneutralmateriality 4/10

17-04-2026

MFA Financial, Inc. filed Definitive Additional Proxy Materials (DEFA14A) on April 17, 2026, pursuant to Schedule 14A under Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. This supplements proxy statement information ahead of a shareholder meeting.

  • ·Filing marked as Definitive Additional Materials
  • ·Filed by the Registrant (☒)
  • ·No fee required (☒)
Revolution Medicines, Inc.8-Kpositivemateriality 9/10

17-04-2026

Revolution Medicines, Inc. issued $500,000,000 aggregate principal amount of 0.50% Convertible Senior Notes due 2033 on April 17, 2026, under an indenture with U.S. Bank Trust Company, National Association. The notes accrue interest at 0.50% per annum, payable semi-annually starting November 1, 2026, with an initial conversion rate of 5.0302 shares per $1,000 principal (approximately $198.80 per share), maturing on May 1, 2033. The issuance followed an underwriting agreement dated April 14, 2026, with J.P. Morgan Securities LLC, TD Securities (USA) LLC, and Guggenheim Securities, LLC.

  • ·Notes are senior unsecured obligations, effectively subordinated to secured indebtedness and structurally subordinated to subsidiary liabilities.
  • ·Conversion permitted before February 1, 2033 only upon certain events; thereafter at any time until close of business two trading days before maturity.
  • ·Redemption possible on or after May 6, 2030 if stock price exceeds 130% of conversion price over specified periods.
  • ·Fundamental Change allows noteholders to require repurchase at principal plus accrued interest.
  • ·Events of Default include payment defaults (30-day cure for interest), conversion failures (5-day cure), covenant breaches (60-day cure), and cross-defaults on $100M+ indebtedness.
FIRST FINANCIAL BANKSHARES INC8-Kmixedmateriality 9/10

17-04-2026

First Financial Bankshares, Inc. (FFIN) reported Q1 2026 net income of $71.54 million, up 16.6% YoY from $61.35 million but down slightly QoQ from $73.31 million, with net interest income rising to $134.79 million (13.5% YoY growth) driven by higher average interest-earning assets of $14.54 billion and an improved net interest margin of 3.86%. However, noninterest expenses increased 9.2% YoY to $76.77 million due to higher salary costs and other expenses, total assets declined QoQ to $15.39 billion, and deposits plus repurchase agreements fell slightly QoQ to $13.31 billion amid public fund declines. Credit quality remained strong with nonperforming assets at 0.66% of loans and foreclosed assets, down from 0.78% YoY.

  • ·Trust fees increased to $13.36M in Q1 2026 from $12.65M YoY.
  • ·Service charges on deposits decreased to $6.08M from $6.18M YoY due to lower overdraft fees.
  • ·Mortgage income rose to $4.28M from $2.83M YoY.
  • ·Net charge-offs were $0.36M in Q1 2026, up from $0.24M YoY.
  • ·Salary and employee benefit costs up to $45.98M from $42.14M YoY.
REGIONS FINANCIAL CORP8-Kmixedmateriality 10/10

17-04-2026

Regions Financial Corp reported 1Q26 net income available to common shareholders of $539 million and diluted EPS of $0.62, up 5% and 15% respectively on an adjusted YoY basis, with total revenue of $1,873 million reflecting 5% YoY growth but down 2.5% QoQ amid a 2.6% drop in net interest income to $1,248 million. Ending loans increased 2.4% QoQ to $97,926 million driven by 4.3% growth in business lending, while ending deposits rose 0.6% QoQ to $131,880 million; however, consumer lending balances declined 1.3% QoQ and net interest margin compressed 3 bps to 3.67%. Credit quality strengthened with non-performing loans at 0.71% (down 2 bps QoQ) and ACL ratio at 1.68% (down 8 bps QoQ), supporting ROATCE of 18.26%.

  • ·CET1 ratio 10.7% (estimated) in 1Q26, down from 10.9% in 4Q25
  • ·Efficiency ratio 56.6% in 1Q26, improved from 56.8% in 4Q25
  • ·Business services criticized loans 5.15% of business loans in 1Q26, down 16 bps QoQ
  • ·Provision for credit losses $91 million in 1Q26, down from $115 million in 4Q25
Oportun Financial Corp8-Kpositivemateriality 9/10

17-04-2026

Oportun Financial Corporation (Nasdaq: OPRT) appointed Doug Bland as Chief Executive Officer and member of the Board of Directors, effective April 20, 2026, following a comprehensive search. Bland brings over 30 years of experience in consumer financial services, including senior leadership at PayPal where he led the Global Credit business, and prior roles at Swift Financial, Bank of America, and others. Since inception, Oportun has provided more than $21.8 billion in responsible credit, saved members over $2.5 billion in interest and fees, and helped members set aside an average of more than $1,800 annually.

  • ·Announcement date: April 16, 2026
  • ·Investor Contact: Dorian Hare (650) 590-4323 ir@oportun.com
  • ·Media Contact: FGS Global - John Christiansen / Bryan Locke (Oportun@fgsglobal.com)
  • ·Bland will step down from the board of WebBank concurrent with joining Oportun
NEWS CORP8-Kneutralmateriality 3/10

17-04-2026

News Corporation disclosed via 8-K the provision of information to the Australian Securities Exchange (ASX) regarding its ongoing $1 billion stock repurchase program authorizing acquisitions of Class A (NWSA) and Class B (NWS) common stock, as detailed in Exhibits 99.1 and 99.2. The Company provides daily ASX disclosures of any repurchase transactions under the program, which is also reported in quarterly and annual filings. Forward-looking statements highlight uncertainties including market conditions and stock prices.

  • ·Filing Date: April 17, 2026
  • ·Date of Earliest Event Reported: April 16, 2026
  • ·Securities: Class A Common Stock (NWSA), Class B Common Stock (NWS) on Nasdaq Global Select Market
TRUIST FINANCIAL CORP8-Kmixedmateriality 9/10

17-04-2026

Truist reported first quarter 2026 net income available to common shareholders of $1.38 billion and diluted EPS of $1.09, up 19% and 25% YoY respectively, with total revenue TE of $5.20 billion (+5.1% YoY) driven by higher noninterest income (+11.6%) and ROTCE improving to 13.8%. However, total revenue TE declined 1.9% QoQ due to a 2.8% drop in NII TE and 5 bps contraction in NIM TE to 3.02%, while noninterest expense fell 5.9% QoQ but rose 2.6% YoY amid higher personnel costs. Average loans grew 0.7% QoQ and asset quality remained strong, with CET1 ratio stable at 10.8%; the company repurchased $1.1 billion in shares and targets long-term ROTCE of 16-18%.

  • ·Average commercial loans up 1.8% QoQ to $198.6B, consumer loans down 0.9% QoQ to $123.5B
  • ·Average noninterest-bearing deposits down 2.1% QoQ to $103.4B (25.9% of total deposits)
  • ·NCO ratio 0.61% (up 4 bps QoQ, flat YoY); ALLL ratio flat at 1.53% QoQ
  • ·LCR average 110% for 1Q26
  • ·Personnel expense down 5.0% QoQ but up 7.7% YoY to $1.73B
DIGITAL ALLY, INC.8-Kneutralmateriality 7/10

17-04-2026

Kustom Entertainment, Inc. (KUST) announced on April 17, 2026, that it entered into a revised non-binding Memorandum of Understanding (MOU) with Cycurion, Inc. (CYCU) regarding the contemplated divestiture of its Video Solutions Segment. This revised MOU replaces the prior non-binding MOU dated January 22, 2026. The filing includes forward-looking statements noting risks such as transaction closing uncertainties and integration challenges.

  • ·Previous MOU dated January 22, 2026
  • ·Filing includes Exhibit 99.1: Press Release dated April 17, 2026
Ally Financial Inc.8-Kmixedmateriality 9/10

17-04-2026

Ally Financial reported strong Q1 2026 results with GAAP EPS of $0.93 (up from a $0.82 loss YoY) and adjusted EPS of $1.11 (up 90% YoY), alongside core pre-tax income of $470 million (up $223 million YoY) and core ROTCE of 11.1% (up 440 bps YoY). GAAP total net revenue reached $2,102 million, up 36% YoY but down 1% QoQ, while NIM ex-OID improved to 3.52% (up 17 bps YoY). However, Automotive Finance pre-tax income fell $39 million YoY to $336 million, Dealer Financial Services declined 99 million QoQ, and Insurance pre-tax income dropped 63 million QoQ to $28 million.

  • ·Common equity tier 1 ratio of 10.1%, up 60 bps YoY
  • ·Retail auto net charge-offs of 197 bps, down 15 bps YoY
  • ·Retail auto delinquencies 30+ days past due at 4.60%, down 17 bps YoY
  • ·End-of-period auto earning assets $119.3 billion, up $6.0 billion YoY
  • ·Corporate Finance HFI portfolio with no new non-performing loans and ROE of 26%
FrontView REIT, Inc.DEF 14Aneutralmateriality 5/10

17-04-2026

FrontView REIT, Inc. issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 27, 2026, at 10:00 a.m. CDT. Stockholders of record as of April 2, 2026, will vote on electing seven director nominees (Stephen Preston, Charles Fitzgerald, Elizabeth Frank, Robert Green, Noelle LeVeaux, Ernesto Perez, and Daniel Swanstrom) and ratifying KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The proxy materials and Annual Report for the fiscal year ended December 31, 2025, are available online.

  • ·Record Date: close of business on April 2, 2026
  • ·Annual Meeting access: www.virtualshareholdermeeting.com/FVR2026 (online check-in from 9:30 a.m. CDT)
  • ·Voting for directors: plurality of votes cast (no cumulative voting)
  • ·Voting for auditor ratification: majority of votes cast
  • ·Company address: 3131 McKinney Avenue, Suite L10, Dallas, Texas 75204
  • ·Proxy materials first available: April 17, 2026
ABBOTT LABORATORIES8-Kneutralmateriality 6/10

17-04-2026

Abbott Laboratories disclosed that on April 10, 2026, the United States District Court for the Northern District of Illinois issued an order preliminarily approving a proposed settlement in the consolidated shareholder derivative litigation, In re Abbott Laboratories Infant Formula Shareholder Derivative Litigation, involving six lawsuits against certain current and former directors and officers. The order directs the issuance of notice to shareholders and sets a final settlement hearing. No financial terms of the settlement were disclosed in the filing.

  • ·Litigation previously disclosed in Form 10-K for fiscal years ended December 31, 2024 and December 31, 2025
  • ·Notice of Proposed Settlement filed as Exhibit 99.1
Chime Financial, Inc.DEFA14Aneutralmateriality 4/10

17-04-2026

Chime Financial, Inc. (CHYM) filed Definitive Additional Proxy Materials (DEFA14A) on April 17, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as definitive additional materials. No substantive proxy details, financial data, or voting matters are included in the provided content.

First City Capital Management, Inc.13F-HRneutralmateriality 4/10

17-04-2026

First City Capital Management, Inc. filed its 13F-HR report disclosing 160 equity positions held with sole voting power, totaling $188670819 in market value as of March 31, 2026. The portfolio is diversified across individual stocks such as Exxon Mobil Corp ($7475377), State Street SPDR S&P 500 ETF ($8390687), and Vanguard S&P 500 ETF ($8052943), as well as various ETFs. No changes from prior periods or performance metrics are detailed in the filing.

  • ·All 160 positions held with sole voting and disposition power (SH SOLE).
  • ·Portfolio heavily weighted towards ETFs including multiple Innovator ETFs, iShares, and Invesco products.
  • ·Top individual stock holdings include Apple Inc (13981 shares, $3548296), NVIDIA (34336 shares, $5988225), and Coca Cola Co (56199 shares, $4273953).
Chime Financial, Inc.DEF 14Aneutralmateriality 6/10

17-04-2026

Chime Financial, Inc. (CHYM) filed its 2026 Proxy Statement (DEF 14A) on April 17, 2026, for the virtual Annual Meeting of Stockholders on June 2, 2026, with a record date of April 8, 2026. Stockholders will vote on electing three Class I directors (Christopher Britt, Shawn Carolan, James Dunne) for terms until 2029, ratifying Ernst & Young LLP as independent auditors for FY ending December 31, 2026, approving NEO compensation on an advisory basis, and selecting the frequency (recommends every one year) for future say-on-pay votes. As of the record date, 349,836,050 Class A shares (1 vote each) and 32,132,289 Class B shares (20 votes each) were outstanding.

  • ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/CHYM2026.
  • ·Board recommends voting FOR all director nominees, auditor ratification, say-on-pay approval, and one-year frequency for future advisory votes.
  • ·Directors elected by majority of votes cast; abstentions and broker non-votes have no effect.
Dare Bioscience, Inc.8-Kneutralmateriality 3/10

17-04-2026

On April 16, 2026, Gregory W. Matz voluntarily resigned from his position as a Class II director of Daré Bioscience, Inc. and was simultaneously reappointed as a Class III director solely to rebalance the board's three classes. His service on the board continues uninterrupted, with no changes to committee assignments. Class III directors, including Mr. Matz and Sabrina Martucci Johnson, will stand for election at the 2026 annual meeting of stockholders.

  • ·Board of directors currently consists of six members, divided into three classes.
  • ·Class II term originally expiring at 2028 annual meeting; reclassified to Class III expiring at 2026 annual meeting.
FrontView REIT, Inc.DEFA14Aneutralmateriality 5/10

17-04-2026

FrontView REIT, Inc. filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting scheduled for May 27, 2026. Shareholders are asked to vote on the election of seven director nominees—Stephen Preston, Charles Fitzgerald, Elizabeth Frank, Robert Green, Noelle LeVeaux, Ernesto Perez, and Daniel Swanstrom—and the ratification of KPMG LLP as the independent registered public accounting firm for the year ending December 31, 2026. Proxy materials are available online at www.ProxyVote.com, with voting deadline May 26, 2026, 11:59 PM ET.

  • ·Annual Meeting: May 27, 2026, 10:00 AM CDT, virtually at www.virtualshareholdermeeting.com/FVR2026
  • ·Request proxy materials by May 13, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com
  • ·Address: 3131 McKinney Ave., Suite L10, Dallas, TX 75204
Bank of New York Mellon Corp8-K/Amixedmateriality 7/10

17-04-2026

On April 14, 2026, The Bank of New York Mellon Corporation (BNY) held its Annual Meeting of Stockholders, where all 11 director nominees, including Charles F. Lowrey, were elected by majority votes cast, advisory approval of 2025 named executive officer compensation passed narrowly at 55.56% For versus 44.44% Against, and ratification of KPMG LLP as auditors for 2026 passed overwhelmingly at 98.11% For. The Board appointed Charles F. Lowrey to its Risk Committee and Corporate Governance, Nominating and Social Responsibility Committee effective immediately, amending prior disclosure of his election on December 9, 2025 (effective February 15, 2026).

  • ·Annual Meeting held April 14, 2026; proxy statement dated March 5, 2026.
  • ·Charles F. Lowrey elected to Board December 9, 2025, effective February 15, 2026.
  • ·Director election votes (For/Against/Abstain/Broker Non-Votes): Linda Z. Cook (557,476,289 / 14,040,474 / 1,029,945 / 50,748,197); Joseph J. Echevarria (517,158,037 / 54,616,170 / 772,501 / 50,748,197); M. Amy Gilliland (550,786,227 / 21,016,295 / 744,186 / 50,748,197); Jeffrey A. Goldstein (543,701,685 / 28,115,071 / 729,952 / 50,748,197); K. Guru Gowrappan (550,466,083 / 21,226,082 / 854,543 / 50,748,197); Charles F. Lowrey (569,765,552 / 2,037,150 / 744,006 / 50,748,197); Sandra E. O’Connor (568,067,727 / 3,771,362 / 707,619 / 50,748,197); Elizabeth E. Robinson (530,536,402 / 40,955,989 / 1,054,317 / 50,748,197); Rakefet Russak-Aminoach (567,593,596 / 4,054,694 / 898,418 / 50,748,197); Robin Vince (542,214,387 / 29,502,854 / 829,467 / 50,748,197); Alfred W. Zollar (567,676,532 / 4,060,517 / 809,659 / 50,748,197).
  • ·Compensation vote raw: For 317,099,734; Against 253,650,298; Abstain 1,796,676.
  • ·KPMG ratification raw: For 610,876,407; Against 11,747,746; Abstain 670,752.
MFA FINANCIAL, INC.DEF 14Aneutralmateriality 6/10

17-04-2026

MFA Financial, Inc.'s 2026 Proxy Statement details governance policies including review of related party transactions exceeding $120,000, director nomination processes open to stockholder recommendations by December 21, 2026, and communication channels with the Board. As of December 31, 2025, the company held approximately $12.3 billion in aggregate mortgage, mortgage-related, and real estate investments. The Board held 6 meetings and 13 unanimous written consents in 2025, with all directors attending at least 75% of meetings and the 2025 Annual Meeting.

  • ·Stockholder recommendations for director nominees at 2027 Annual Meeting must be submitted by close of business on December 21, 2026.
  • ·Independent directors meet in executive session at least four times per year, presided over by Laurie S. Goodman.
  • ·Board communications directed to Secretary at One Vanderbilt Avenue, 48th Floor, New York, New York 10017.
New ERA Energy & Digital, Inc.8-Kpositivemateriality 7/10

17-04-2026

New Era Energy & Digital, Inc. appointed Andrew Casazza as Chief Corporate Officer effective April 28, 2026, with an annual base salary of $415,000, target bonus up to 40% of base salary, and 400,000 RSUs vesting over four years. The employment agreement includes severance of 100% or 150% of base salary depending on change in control, along with standard benefits and restrictive covenants. Under Regulation FD, the company disclosed that its flagship project, Texas Critical Data Centers LLC, has potential to support up to 1.4 GW of gross power production.

  • ·Andrew Casazza, age 58, previously served as co-founder, CFO, and board member of Windy Cove Energy II (since 2017) and Pure Earth Plasma Holdings (since 2021).
  • ·Severance upon termination without Cause or for Good Reason: 100% of base salary pre-Change in Control, 150% post-Change in Control, plus pro-rated bonus and benefits continuation.
  • ·Restrictive covenants include 18-month non-solicit of clients and 24-month non-solicit of employees post-termination.
  • ·RSUs granted as inducement awards, not pursuant to the Equity Incentive Plan.
  • ·Appointment announced April 17, 2026, for event dated April 14, 2026.
Tradewinds Universal10-K/Amixedmateriality 9/10

17-04-2026

Tradewinds Universal reported a significant net loss of $892,877 for the year ended December 31, 2025, worsening from $115,743 in 2024, driven by a 368% surge in operating expenses to $1,026,099, primarily from consulting costs jumping to $886,105, while revenue declined 22% YoY to $133,222 and gross profit fell 11% to $133,222. However, the company raised capital through stock issuances totaling approximately $1.17M in additional paid-in capital, boosting total assets to $307,333 from $31,510 and cash to $16,638 from $210. Shares outstanding increased to 42,690,580 from 32,170,000.

  • ·Auditor: Fruci & Associates II, PLLC (PCAOB #05525) since 2025; another report from PCAOB ID 6920.
  • ·On June 8, 2025, issued 1,500,000 shares for services to a non-affiliated entity.
  • ·Shares issued for assets valued at $200,000 (173,913 shares).
  • ·Net cash used in operating activities: $57,572 in 2025 vs $28,003 in 2024.
  • ·No accounts payable or other liabilities as of Dec 31, 2025 or 2024.
Pacific Airport Group20-Fmixedmateriality 9/10

17-04-2026

For the year ended December 31, 2025, Pacific Airport Group reported total revenues of Ps. 41,408,540 thousand ($2,293,360 thousand), up 23.2% YoY from Ps. 33,614,374 thousand in 2024, driven by 19.4% growth in aeronautical revenues to Ps. 22,821,817 thousand and 26.5% increase in non-aeronautical revenues to Ps. 9,704,090 thousand. Net profit rose 12.7% to Ps. 10,000,609 thousand ($556,619 thousand), with operating income up 16.8% to Ps. 17,580,115 thousand; however, total terminal passengers grew modestly 2.5% to 63,686 thousand amid flat-to-declining trends in prior years, and cash and cash equivalents declined to Ps. 10,453,198 thousand from Ps. 13,466,027 thousand.

  • ·Guadalajara contributed 28.1% of total revenues in 2025, followed by Los Cabos (16.5%), Tijuana (13.7%), and Puerto Vallarta (12.6%).
  • ·Dividends per share Ps. 16.8400 ($0.9353) in 2025.
  • ·Net cash flows from operating activities Ps. 18,249,740 thousand in 2025, up from Ps. 16,674,340 thousand in 2024.
  • ·Finance cost - net increased to Ps. 3,466,277 thousand in 2025 from Ps. 2,934,903 thousand in 2024.
CEL SCI CORPS-1neutralmateriality 8/10

17-04-2026

CEL-SCI Corporation, a late-stage biotech company developing Multikine for head and neck cancer and LEAPS technology for rheumatoid arthritis, filed an S-1 registration on April 17, 2026, to offer up to 3,440,367 shares of common stock at an assumed $4.36 per share (last NYSE American price on April 14, 2026) on a best-efforts basis via ThinkEquity LLC, plus pre-funded warrants for the same number of shares exercisable at $0.0001. The offering has no minimum amount, allowing immediate use of proceeds despite risks of insufficient funding for business goals. No current financial performance data is provided, but the filing emphasizes high speculation and incorporation of 2025 10-K risks.

  • ·Registrant classified as non-accelerated filer and smaller reporting company.
  • ·Offering pursuant to Rule 415 for delayed or continuous basis.
  • ·Placement agent not required to sell any specific number or amount; no escrow or minimum closing requirement.
  • ·Shares traded on NYSE American under symbol CVM.
Earth Science Tech, Inc.8-Kneutralmateriality 4/10

17-04-2026

Earth Science Tech, Inc. (ETST), a pharmaceutical preparations company, filed a Form 8-K on April 17, 2026, under Items 5.03 and 9.01, announcing amendments to its charter or bylaws. The filing includes exhibits but provides no specific details on the nature of the amendments or any associated financial impacts. No quantitative metrics, period-over-period comparisons, improvements, declines, or flat performance are disclosed in the available content.

  • ·Filing size: 775 KB
  • ·Accession number: 0001493152-26-017907
  • ·Company CIK: 0001538495
  • ·SIC: 2834 - Pharmaceutical Preparations
  • ·Fiscal Year End: March 31
Bayview Acquisition Corp8-Kneutralmateriality 4/10

17-04-2026

Bayview Acquisition Corp deposited $50,000 into its trust account on April 17, 2026, to extend the deadline for consummating its initial business combination from April 19, 2026, to May 19, 2026. This represents the fifth of up to six extensions permitted under the company's Second Amended and Restated Articles of Association.

  • ·Securities registered: Units (BAYAU), Ordinary Shares par value $0.0001 (BAYA), Rights (BAYAR), all on The Nasdaq Stock Market LLC
  • ·Company is an emerging growth company
Emmaus Life Sciences, Inc.8-Kneutralmateriality 6/10

17-04-2026

Emmaus Life Sciences, Inc. appointed Henry H. Du to its Board of Directors on April 16, 2026, via written consent, to fill the vacancy created by Jon Kuwahara's resignation; Mr. Du is also expected to become the sole member of the Audit Committee. Mr. Du, age 48, serves as Vice President – Finance Accounting and interim Chief Financial Officer at Alpha Cognition, Inc. (NASDAQ: ACOG) since October 2024. There are no family relationships between Mr. Du and other directors or officers, and he has no disclosable transactions under Item 404(a).

  • ·Mr. Du is a Certified Public Accountant and holds a Bachelor of Arts degree from Claremont McKenna College.
  • ·Mr. Du expected to be compensated for Board services in the same manner as other directors.
Stonebridge Financial Group, LLC / MO13F-HRneutralmateriality 5/10

17-04-2026

Stonebridge Financial Group, LLC / MO filed its 13F-HR on April 17, 2026, reporting equity holdings as of March 31, 2026, totaling $118,609,807 across 165 positions, all held solely. Top holdings include NVIDIA Corporation ($5,454,999, 31,279 shares), Apple Inc. ($5,034,884, 19,839 shares), and Microsoft Corp. ($2,763,968, 7,467 shares), with significant allocations to ETFs like iShares TR Global 100 ETF ($6,629,037, 54,799 shares) and Vanguard Index FDS Value ETF ($3,531,054, 17,997 shares). No prior period comparisons or changes are disclosed in the filing.

  • ·Filing period end date: March 31, 2026
  • ·Business address: 3770 South Lindbergh Boulevard, Suite 102, St. Louis, MO 63127
  • ·All holdings reported as SOLE with no shared or other voting authority
Sovereign Financial Group, Inc.13F-HRneutralmateriality 5/10

17-04-2026

Sovereign Financial Group, Inc. filed its 13F-HR on April 17, 2026, reporting a diversified portfolio of 365 equity positions valued at $575,595,652 as of March 31, 2026. Holdings include a mix of ETFs such as Vanguard FTSE Developed Markets ETF ($34,159,751) and iShares products, alongside individual stocks like Microsoft Corp and McDonalds Corp. All positions are held with sole voting and investment discretion.

  • ·Portfolio domiciled in Stamford, CT; business phone (203) 883-6006.
  • ·All 365 positions reported with sole voting power (SH SOLE) and no shared or none voting power.
  • ·SEC file number: 028-20792; CIK: 0001846175.
LCI INDUSTRIES8-Kneutralmateriality 4/10

17-04-2026

LCI Industries filed an 8-K on April 17, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, referencing a press release dated the same day attached as Exhibit 99.1. The filing discloses events described in the press release but provides no specific financial or operational details within the form itself. No performance metrics, positive or negative, are reported.

  • ·Filing Type: 8-K
  • ·Commission File Number: 001-13646
  • ·I.R.S. Employer Identification No.: 13-3250533
  • ·Principal executive offices: 3501 County Road 6 East, Elkhart, Indiana 46514
  • ·Telephone: (574) 535-1125
  • ·Securities: Common Stock, $.01 par value (LCII) on New York Stock Exchange
Tyra Biosciences, Inc.8-Kpositivemateriality 6/10

17-04-2026

Tyra Biosciences, Inc. increased the number of authorized directors from nine to ten and appointed Habib J. Dable as a Class II director effective April 16, 2026, upon recommendation of the Nominating and Corporate Governance Committee. Mr. Dable, a biopharmaceutical industry veteran who served as CEO of Acceleron Pharma Inc. until its acquisition by Merck and held senior roles at Bayer AG, was granted options to purchase 44,400 shares of common stock vesting over 36 months under the Non-Employee Director Compensation Program. The appointment involves no related arrangements or disclosable transactions, and the Board affirmed his independence.

  • ·Mr. Dable, age 56, holds a bachelor’s degree in business administration and an MBA from the University of New Brunswick.
  • ·Mr. Dable currently serves on boards of Spyglass Pharma (since Feb 2026), Relay Therapeutics (since Nov 2025), Day One Biopharmaceuticals (since Jan 2024), and PepGen (since Sep 2022).
  • ·Options have exercise price equal to fair market value on grant date and vest in equal monthly installments over 36 months.
Tyra Biosciences, Inc.DEF 14Aneutralmateriality 5/10

17-04-2026

Tyra Biosciences, Inc. has issued a proxy statement for its virtual Annual Meeting of Stockholders on May 28, 2026, at 10:00 a.m. Pacific Time, seeking approval to elect Habib J. Dable, Susan Moran, M.D., M.S.C.E., and Robert More as Class II directors for a three-year term expiring in 2029 and to ratify Ernst & Young LLP as independent public accounting firm for the fiscal year ending December 31, 2026. As of the Record Date of April 2, 2026, 59,485,237 shares of common stock were outstanding and entitled to vote, with each share carrying one vote. Proxy materials are available electronically at www.proxydocs.com/TYRA, and the Board recommends voting FOR both proposals.

  • ·Quorum requires holders of a majority in voting power of Common Stock entitled to vote on Record Date.
  • ·Registration to attend virtual Annual Meeting required by 2:00 p.m. Pacific Time on May 26, 2026, at www.proxydocs.com/TYRA using Control Number.
  • ·Company address: 2656 State Street, Carlsbad, California 92008.
Corebridge Financial, Inc.8-Kpositivemateriality 6/10

17-04-2026

Corebridge Financial, Inc. (NYSE: CRBG) elected Hirotaka Inoue as a director effective April 21, 2026, to replace Minoru Kimura, who departs effective April 20, 2026; Inoue is a Nippon Life Insurance Company designee with expertise in global insurance regulation, financial risk, and monetary policy from roles at Nippon Life and the Bank of Japan. Alan Colberg, Board Chair, highlighted Inoue's value to the company. Corebridge manages $385 billion in assets under management and administration as of December 31, 2025.

  • ·Filing date: April 17, 2026
  • ·Investor contact: Işıl Müderrisoğlu (investorrelations@corebridgefinancial.com)
  • ·Media contact: Paul Miles (media.contact@corebridgefinancial.com)
Tyra Biosciences, Inc.DEFA14Aneutralmateriality 4/10

17-04-2026

Tyra Biosciences, Inc. issued a DEFA14A filing providing notice of proxy materials availability for its Annual Meeting of Stockholders on May 28, 2026, at 10:00 AM Pacific Time, for stockholders of record as of April 2, 2026. The meeting includes Proposal 1 to elect three Class II directors—Habib J. Dable, Susan Moran, M.D., M.S.C.E., and Robert More—for a three-year term expiring at the 2029 Annual Meeting, and Proposal 2 to ratify Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The Board of Directors recommends a vote FOR both proposals.

  • ·Proxy materials available online at www.proxydocs.com/TYRA; paper copies requested by May 18, 2026.
  • ·Meeting held live via webcast; use 12-digit control number to vote online at www.investorelections.com/TYRA.
  • ·Filing date: April 17, 2026.
DANAHER CORP /DE/8-Kpositivemateriality 9/10

17-04-2026

Danaher Corporation entered into a new $5 billion 364-day revolving credit agreement on April 16, 2026, with Bank of America, N.A. as Administrative Agent and multiple major banks including Barclays Bank PLC, BNP Paribas Securities Corp., Citibank, N.A., and others as lenders, documentation agents, and joint lead arrangers/bookrunners. The facility offers borrowings at competitive rates tied to Danaher's debt ratings (e.g., Term SOFR margins from 0.585% at AA-/Aa3 to 1.085% at BBB/Baa2, with a flat 0.04% facility fee). No declines or flat performance noted in the agreement terms.

  • ·Agreement effective as of April 16, 2026; filed with SEC on April 17, 2026
  • ·CUSIP Numbers: Deal 235854BA3, Revolver 235854BB1
  • ·Pricing determined by S&P/Moody’s senior unsecured debt ratings; initial rate based on certificate under Section 4.01(a)(vi)
  • ·Availability Period from Closing Date to earliest of Scheduled Termination Date, commitment termination, or Lender commitment end
CHEMUNG FINANCIAL CORP8-Kmixedmateriality 9/10

17-04-2026

Chemung Financial Corporation reported record Q1 2026 net income of $9.2 million ($1.91 per share), up 19.5% from Q4 2025's $7.7 million ($1.61) and 53.3% from Q1 2025's $6.0 million ($1.26), driven by 19.2% YoY net interest income (NII) growth to $23.6 million and annualized loan growth of 7.5%. However, NII declined 0.8% QoQ from $23.8 million, non-interest income fell 6.0% QoQ to $6.3 million, and net interest margin was nearly flat at 3.60%. The adjusted efficiency ratio improved to a record low of 58.27%, with dividends declared at $0.34 per share.

  • ·Opened representative office in downtown Buffalo, New York in March 2026 to support Canal Bank division.
  • ·Period-end loan growth nearly 15% in Western New York Canal Bank division; over 7% annualized in Capital Bank division.
  • ·Average total loans up $69.1M QoQ and $214.5M YoY.
  • ·Fully taxable equivalent net interest margin 3.60% (down 1 bp QoQ).
  • ·Provision for credit losses $0.6M, down from $1.1M QoQ due to $0.7M recovery and CECL model update.
Stewardship Advisors, LLC13F-HRneutralmateriality 5/10

17-04-2026

Stewardship Advisors, LLC filed its quarterly 13F-HR on April 17, 2026, disclosing 168 equity positions valued at a total of $435,254,990 as of March 31, 2026, all held with sole voting power and no reported put/call options or other managers. The portfolio is heavily weighted toward ETFs from providers like Invesco, Dimensional, iShares, and Schwab, alongside individual stocks such as Apple Inc (8,031 shares), NVIDIA Corporation (10,692 shares), and Microsoft Corp (3,246 shares). No changes from prior periods are indicated in the filing.

  • ·Address: 321 W Main St, Mount Joy, PA 17552
  • ·All positions reported as SH SOLE with 0 SH PRN, 0 SH VPN, 0 OP CALL, 0 OP PUT
  • ·Central Index Key: 0001733219
Roxbury Financial LLC13F-HRneutralmateriality 4/10

17-04-2026

Roxbury Financial LLC disclosed its quarterly 13F-HR holdings as of March 31, 2026, totaling $111,214,848 across 392 positions, all managed with sole investment discretion and primarily sole voting authority. Top holdings include Amazon.com Inc. ($2,944,063 for 14,136 shares), Procter & Gamble Co. ($1,235,742 for 8,555 shares), Costco Wholesale Corp. ($1,163,311 for 1,167 shares), Prudential Financial Inc. ($1,193,932 for 12,222 shares), and Johnson & Johnson ($1,137,110 for 4,652 shares). The filing, submitted April 17, 2026, shows a diverse portfolio spanning stocks, ETFs, and ADRs with no shared or other voting authority reported.

  • ·Portfolio includes a mix of individual stocks (e.g., Microsoft Corp. $5,060,987 for 13,672 shares), ETFs (e.g., Fidelity Blue Chip Growth ETF $4,075,768 for 81,320 shares), and ADRs.
  • ·All holdings reported as SH (shares) with sole investment discretion; minor discrepancies in voting authority shares (often 1 share less) across positions.
  • ·SEC file number: 028-24692; EIN: 851329580; State of incorporation: NJ.
ENB Financial Corp8-K/Aneutralmateriality 9/10

17-04-2026

ENB Financial Corp completed its acquisition of Cecil Bancorp, Inc. effective February 1, 2026, pursuant to an agreement dated August 12, 2025. This Form 8-K/A amends the original February 2, 2026 filing to include audited consolidated financial statements of Cecil for the years ended December 31, 2024 and 2023 (Exhibit 99.1), unaudited statements for the nine months ended September 30, 2025 and 2024 (Exhibit 99.2), and unaudited pro forma combined financial information for ENB (Exhibit 99.3). No performance metrics or changes are detailed in the filing text.

  • ·Agreement and Plan of Stock Acquisition dated August 12, 2025
  • ·Original Form 8-K filed February 2, 2026
  • ·Pro forma combined statement of condition as of September 30, 2025
  • ·Pro forma combined statement of income for nine months ended September 30, 2025 and year ended December 31, 2024
Greenbush Financial Group, LLC13F-HRneutralmateriality 5/10

17-04-2026

Greenbush Financial Group, LLC filed its 13F-HR report on April 17, 2026, disclosing equity holdings as of March 31, 2026, totaling $302028273 across 36 positions held on a sole discretionary basis. Top holdings include Vanguard S&P 500 ETF (41254255 value, 69039 shares), Vanguard Total Bond Market ETF (23536425 value, 319615 shares), and Vanguard Value ETF (20004443 value, 101959 shares). Other notable positions feature technology stocks like NVIDIA (4604763 value, 26403 shares), Tesla (5473475 value, 14724 shares), and Apple (4579030 value, 18043 shares).

  • ·Filing managed by Robert M. Mangold Jr., Partner, contact 518-477-6686
  • ·Firm address: 159 Wolf Road, Ste. 101, Albany, NY 12205
  • ·All positions reported as sole discretionary with zero shared, none, or other voting authority
PROVIDENT FINANCIAL HOLDINGS INC8-Knegativemateriality 6/10

17-04-2026

Provident Financial Holdings, Inc. announced with sadness the passing of Director William E. Thomas on April 13, 2026. The company extends its deepest condolences to Mr. Thomas’ family, friends, and colleagues. The Board of Directors will address the vacancy at a future meeting.

Capital Squared Financial LLC13F-HRneutralmateriality 4/10

17-04-2026

Capital Squared Financial LLC (CIK 0002128691) filed its 13F-HR on April 17, 2026, reporting equity holdings as of June 30, 2025, with a total portfolio market value of $85,773,852 across 66 positions. The portfolio consists primarily of shares in large technology companies like Microsoft Corp, NVIDIA Corporation, Apple Inc, Amazon.com Inc, and Alphabet Inc, as well as various iShares, Schwab Strategic Trust, and Vanguard ETFs. This quarterly disclosure provides a snapshot of the firm's discretionary managed securities exceeding the $100 million reporting threshold; no performance metrics or prior-period comparisons are included.

  • ·Business address: 1451 Rockville Pike, Suite 250, Rockville, MD 20852
  • ·Business phone: 240-600-1678
  • ·State of incorporation: MD
  • ·Fiscal year end: December 31
  • ·SEC file number: 028-26814
  • ·Other investment discretion: 0
CIDEL ASSET MANAGEMENT INC13F-HRneutralmateriality 6/10

17-04-2026

CIDEL Asset Management Inc., a Toronto-based institutional investment manager, filed its 13F-HR on April 17, 2026, disclosing total holdings of $1,832,672,800 across 436 positions as of March 31, 2026. Notable positions include Fortis Inc. ($54,567,830), Canadian National Railway Co. ($52,874,330), Apple Inc. ($49,076,130), and Canadian Imperial Bank of Commerce ($46,267,780). This quarterly snapshot provides no period-over-period changes or performance metrics.

  • ·Filing period end date: 2026-03-31
  • ·Filer CIK: 0001621915
  • ·SEC file number: 028-16679
Capital Squared Financial LLC13F-HRneutralmateriality 4/10

17-04-2026

Capital Squared Financial LLC filed its 13F-HR on April 17, 2026, reporting equity holdings as of September 30, 2025, across 78 positions with a total portfolio value of $115.27 million. Top holdings include Microsoft Corp valued at $22.333 million (274,312 shares) and various iShares and Schwab ETFs such as iShares Russell Mid-Cap Value ETF. No period-over-period changes or performance metrics are disclosed in the filing.

  • ·Filer CIK: 0002128691, EIN: 921488404, incorporated in MD
  • ·Business address: 1451 Rockville Pike, Suite 250, Rockville, MD 20852
  • ·No other investment managers included in the report (count: 0)
Capital Squared Financial LLC13F-HRmateriality 4/10

17-04-2026

Leeward Investments, LLC - MA13F-HRneutralmateriality 5/10

17-04-2026

Leeward Investments, LLC - MA filed its 13F-HR on April 17, 2026, reporting 142 equity holdings totaling $2027429488 as of March 31, 2026. The portfolio features significant positions in companies such as Harmonic Inc ($1439881 thousand), Neumark Group Inc ($1482921 thousand), Valley National Bancorp ($1576170 thousand), Permian Resources Corp ($1700602 thousand), and Starwood Property Trust ($1055169 thousand). No period-over-period changes are disclosed in this filing.

  • ·Portfolio address: 10 Winthrop Square, Suite 500, Boston, MA 02110
  • ·All positions reported as SOLE discretion
PARAGON FINANCIAL PARTNERS, INC.13F-HRneutralmateriality 5/10

17-04-2026

PARAGON FINANCIAL PARTNERS, INC. filed its 13F-HR disclosing $176585211 in equity holdings across 77 positions as of March 31, 2026, with no changes indicated from the prior period. Largest positions include STATE STR SPDR S&P 500 ETF T TR UNIT ($22620676), NVIDIA CORPORATION COM ($19868054), VANGUARD WHITEHALL FDS HIGH DIV YLD ($16763073), and EATON VANCE TAX-MANAGED BUY- COM ($14474193). The portfolio remains stable with a focus on ETFs, technology, and dividend-yield strategies.

  • ·Report period end: March 31, 2026
  • ·Filing date: April 17, 2026
  • ·All holdings reported as sole discretionary
  • ·Business address: 5850 Canoga Avenue, Suite 400, Woodland Hills, CA 91367
DEMMING FINANCIAL SERVICES CORP /ADV13F-HRneutralmateriality 5/10

17-04-2026

Demming Financial Services Corp /ADV disclosed total holdings of $137,760,980 across 37 positions in its 13F-HR filing as of March 31, 2026. The portfolio features heavy allocations to Dimensional ETF Trust products, including $48,166,054 in US Core Equity 2 ETF (1,239,464 shares) and $43,743,769 in World Ex US Core ETF (1,287,714 shares). Other notable positions include $943,781 in KeyCorp (47,071 shares) and $796,068 in Farmers National Banc Corp (60,491 shares), with no reported changes or performance metrics.

  • ·Filing date: April 17, 2026
  • ·Report period end: March 31, 2026
  • ·Business address: 13 New Hudson Rd, Aurora, OH 44202
  • ·All holdings reported as sole discretionary with 0 shared or other
MORRIS FINANCIAL CONCEPTS, INC.13F-HRneutralmateriality 4/10

17-04-2026

Morris Financial Concepts, Inc. filed its 13F-HR on April 17, 2026, disclosing 195 equity positions held solely as of March 31, 2026, with a total market value of $294556555. The portfolio is heavily weighted toward ETFs, including top holdings in Schwab Strategic TR US LRG CAP ETF (value 37574215), iShares TR CORE MSCI EAFE (18467314), and Vanguard BD INDEX FDS SHORT TRM BOND (11560490). No changes from prior periods are indicated in this snapshot filing, signed by Chief Compliance Officer N. Tucker Morris.

  • ·Filing period end date: 2026-03-31
  • ·Filer address: 409 COLEMAN BLVD. STE 100, MOUNT PLEASANT, SC 29464
  • ·Business phone: 843-884-6192
  • ·SEC file number: 028-22215
CID Holdco, Inc.DEF 14Aneutralmateriality 4/10

17-04-2026

CID Holdco, Inc., a Delaware-incorporated company in computer integrated systems design (SIC 7373), filed a DEF 14A proxy statement on April 17, 2026, for its annual meeting scheduled for May 12, 2026. The filing includes standard header information such as business address in Bethesda, MD, and EIN 992578850, but no substantive proposals, financial metrics, executive compensation, or governance details are discernible due to apparent text extraction issues. No positive or negative performance indicators are present.

  • ·SEC File Number: 001-42711
  • ·Business address: 7500 Old Georgetown Road, Suite 901, Bethesda, MD 20814
  • ·Business phone: 302-332-4122
  • ·Fiscal year end: December 31
  • ·Central Index Key (CIK): 0002033770
New Covenant Trust Company, N.A.13F-HRneutralmateriality 4/10

17-04-2026

New Covenant Trust Company, N.A. disclosed total holdings of $112,040,907 across 96 positions in its 13F-HR filing as of March 31, 2026. The portfolio is heavily weighted toward ETFs including Vanguard Total Stock Market ETF at $15,104,376, Vanguard Total International Stock Index Fund at $9,836,768, and Vanguard Total Bond Market ETF at $7,981,471, alongside individual stocks such as Apple Inc. ($4,689,785), Microsoft Corp. ($3,498,107), and Nvidia Corp. ($4,121,595). No period-over-period changes are reported in this snapshot filing.

  • ·Filing submitted on April 17, 2026, for period ending March 31, 2026.
  • ·All holdings reported as sole ownership (SH SOLE).
  • ·Contact: Ashley L. Smalley-Ray, Jeffersonville IN, phone 502-510-2437.
Phil A. Younker & Associates, Ltd.13F-HRneutralmateriality 3/10

17-04-2026

Phil A. Younker & Associates, Ltd., an investment advisor based in Fairbanks, AK, filed a 13F-HR on April 17, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $149963739 across 36 positions, all held with sole voting and investment discretion. The portfolio is heavily weighted towards ETFs, including Schwab Strategic Trust US Aggregate Bond ETF ($36457606), Schwab Strategic TR US Broad Market ETF ($26630890), and PIMCO ETF TR Enhanced Short Maturity Active ETF ($19712710). No changes or performance metrics are disclosed in this snapshot filing.

  • ·All 36 positions reported with sole shared power of 0.
  • ·SEC file number: 028-25481; CIK: 0002063635.
  • ·Business address: 2130 Hilling Avenue, Fairbanks, AK 99709.

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

More from: S&P 500 Healthcare Sector SEC Filings

🇺🇸 More from United States

View all →